Curated Resources — Prognosis and treatment of Avelumab-related Merkel Cell Carcinoma

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Recommended deep-dive

Prognosis and treatment of Avelumab-related Merkel Cell Carcinoma — Background & Analysis — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.

PubMed Central (PMC)

Reference: PubMed Central (PMC)

Authoritative source for clinical, regulatory, and public-health background reading.